Dəri absesi və follikulit

EBM Klinik protokolları
19.04.2018 • Sonuncu dəyişiklik 23.05.2017
AlexanderSalava

Əsas məqamlar

Etiologiya və terminologiya

Diaqnoz

Müayinələr

Differensial diaqnoz

Müalicə

Yerli müalicə 

Sistem antimikrob vasitələr

Absesin kəsilməsi və drenajı 

Furunkulyoz

Konsultasiya

Masiuk H, Kopron K, Grumann D ym. Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus. J Clin Microbiol 2010;48(5):1527-35. Masiuk H, Kopron K, Grumann D et al. Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus. J Clin Microbiol 2010;48(5):1527-35. Duong M, Markwell S, Peter J et al. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med 2010;55(5):401-7. .Artzi O, Sinai M, Solomon M et al. Recurrent furunculosis in returning travelers: newly defined entity. J Travel Med 2015;22(1):21-5. Miller LG, Daum RS, Creech CB et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med 2015;372(12):1093-103. Rajendran PM, Young D, Maurer T et al. Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007;51(11):4044-8. Demos M, McLeod MP, Nouri K. Recurrent furunculosis: a review of the literature. Br J Dermatol 2012;167(4):725-32.

Yuxarıya